 |
Listen to Your HeartAuthor: Listen to Your Heart
Advances in cardiovascular care are continuously being made, with new research, new treatments, and new recommendations for best practice. Listen to Your Heart is a series of in-depth conversation with experts who are at the forefront of cardiovascular research and medicinepreventing, diagnosing, and treating cardiovascular disease for better patient outcomes. We're starting the conversation with those who are committed to improving heart health for all, and to help provide important information and insight for fellow healthcare professionals keen to target the needs of their patients, particularly those at high-risk for cardiovascular disease. This podcast is intended for healthcare professionals only. Speaker disclosures are available in each episodes notes. The views and opinions expressed in this program are those of the speakers and do not necessarily reflect the views or positions of any entities they represent. Some information contained here may cite the use of an unapproved product in a dosage, for an indication, or in a manner other than recommended. Before prescribing any product always refer to the latest Product Monograph. Financial support for the Listen to Your Heart program was provided by Sanofi Canada. MAT-CA-2201005 Language: en Genres: Health & Fitness, Life Sciences, Science Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Secondary prevention: Practical applications in cardiovascular care
Episode 2
Friday, 27 February, 2026
What are the key challenges in secondary prevention in cardiovascular care, and how can guidelines be translated into practice to optimize patient management? Our host, Dr. Michael Levi, takes a deep dive into secondary prevention in cardiovascular care, with Dr. Lior Bibas, a cardiologist and critical care physician. In this episode, our experts unpack the core principles of secondary prevention in cardiovascular care, exploring how to minimize recurrent events through targeted lipid management, lifestyle interventions, and evidence-based pharmacologic strategies. From defining optimal LDL, non-HDL, and ApoB thresholds to sequencing different pharmacological agents, the discussion offers a practical roadmap for achieving aggressive lipid lowering in high-risk patients. Discover actionable insights grounded in international guidelines that will strengthen your approach to optimizing cardiovascular risk reduction and delivering long-term protection for patients following a vascular event. Don’t miss the conversation! The views and opinions expressed in this episode are those of the speakers and do not necessarily reflect the views or positions of any entities they represent. Declaration of conflict of interest: Dr. Michael Levi: None. Dr. Lior Bibas: None. MAT-CA- 2600003 V(1.0) App 01/26
